Touyun Biotech (01332) announced annual results
- RevenueHK$35.4M
- Net profitHK$3.1bn
- Profit attributable to ownersHK$2.0bn
- Revenue YoY-3.3%
- Net profit YoY+1007.9%
- Depreciation & amortisationHK$21.3M
- Capital expenditureHK$-1.1M
- Interest-bearing debtHK$3.7bn
Source Touyun Biotech



